| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.88B | $2.09B | $2.15B |
| YoY Revenue Growth % | -10.2% | -2.9% | — |
| Gross Profit | $447.8M | $422.6M | — |
| Gross Margin % | 23.8% | 20.2% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $167.8M | $148.2M | $195.2M |
| Operating Margin % | 8.9% | 7.1% | 9.1% |
| Net Income (GAAP) | $56.0M | $52.4M | $89.2M |
| EBITDA (Normalized) | $211.8M | $210.1M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $122.5M | $119.4M | $146.1M |
| Capital Expenditures (CapEx) | $55.0M | $77.4M | — |
| Free Cash Flow (FCF) | $67.5M | $42.0M | $146.1M |
| FCF Margin % | 3.6% | 2.0% | 6.8% |
| Return on Invested Capital (ROIC %) | 8.9% | 8.3% | — |
| Cash & Short-Term Equivalents | — | — | — |
| Total Debt (Short + Long Term) | $914.3M | $925.9M | — |
| Total Stockholders' Equity | $574.0M | $488.7M | — |